All updated as on -
By the end of the forecast period (2023-2030), the global Nifedipine market is projected to be worth $449.99 million at a CAGR of 9.7 percent. The Asia-Pacific region is expected to expand rapidly over the anticipated time frame. This expansion can be attributed to both the improvement of healthcare infrastructure thanks to governments' massive investments in development and the rise in the prevalence of chronic diseases brought on by an ageing population, notably in countries like India and China.
Nifedipine is a medication that blocks calcium's passage through arterial walls and is classified as a calcium channel blocker. Hypertension, irregular heartbeats, and angina are all conditions that nifedipine is used to treat. It also has a number of other medicinal uses, including for conditions including ryanoids syndrome and cephalagra. Market expansion drivers include an ageing population, rising healthcare costs, rising rates of chronic conditions like heart failure, arrhythmias, and hypertension, and rising consumer awareness of the importance of preventative treatment. Market expansion is hampered, however, by both strict government controls and unwanted medication effects include hypotension, stomach ulcers, and congestive heart failure. Opportunities for expansion are expected to arise as a result of ongoing research and development.
We were also tracking the indirect effects of covid-19 across sectors to see how they may affect this market. The impact of the pandemic on the Nifedipine market is examined in this report, both globally and regionally. Market size, market trends, and market expansion are provided for the Nifedipine market, which is broken down here by product type, application, and end-use industry. It also offers a thorough assessment of the factors involved in the growth of the market before and during the covid-19 pandemic. In addition, a pestel analysis of the company's main influencers and entrance barriers was conducted for this report.
Nifedipine works by preventing calcium from crossing the arterial wall and thereby lowering blood pressure. Nifedipine is used to treat hypertension, heart rhythm disorders, and angina. Ryanoids syndrome, cephalalgia, and other illnesses of a similar origin are also treated with this medication. Market growth is being fueled by a number of factors, including an ageing population, rising healthcare spending, an increase in chronic diseases such heart failure, arrhythmias, and hypertension, and an increase in healthcare awareness. However, market growth is hampered by government regulations and negative pharmacological effects include hypotension, stomach ulcers, and congestive heart failure. It is anticipated that the results of R&D efforts would pave the way for further expansion. Nitrendipine and nisoldipine are two examples of dihydropyridine calcium channel blockers used to treat hypertension. Demand for these drugs has increased as the incidence of premature labour has increased in recent years.
This report examines the nifedipine market thoroughly, detailing its history, present state, and projected future state in order to highlight promising investment areas. Both the forces driving and restraining the expansion of the industry have been thoroughly examined. To help stakeholders make the most of the present market prospects, the research offers a quantitative analysis of those potential. Understanding the market's many products requires a deep dive into its many subsets. The competitive outlook of the market has been predicted by profiling key competitors and closely analysing their strategies.
The overall number of people with hypertension is predicted to climb in the future decades as a result of the ageing population and the increasing incidence of obesity and diabetes across Asia. Asia is the largest and most populous continent, home to 60% of the world's current human population of 4.3 billion people and growing rapidly. As a result, hypertension affects a sizable percentage of the population, suggesting rising need for Nifedipine. Nifedipine, a dihydropyridine calcium channel blocker, used to be one of the most widely used hypertension medications, but its popularity has since waned due to safety and tolerability concerns, the introduction of new classes of antihypertensive medications, and an increasing body of data showing the mortality benefit of other classes.
Report Coverage
Global Nifedipine research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Nifedipine report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Nifedipine competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Nifedipine market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Nifedipine market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Nifedipine market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Boehringer Ingelheim GmbH, Novartis AG, Vectura Group plc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, F. Hoffmann La Roche AG, Merck and Co., Inc., Pfizer Inc., GlaxoSmithKline plc
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Nifedipine market based on the below-mentioned segments:
Global Nifedipine Market, By Product
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Global Nifedipine market, By Application
Primary Pulmonary Hypertension
Heart Failure
Raynauds Syndrome
Cephalagra
Bronchial Asthma
Premature Labor
Global Nifedipine market, Regional Analysis
Nifedipine is a medication that blocks calcium's passage through arterial walls and is classified as a calcium channel blocker. Hypertension, irregular heartbeats, and angina are all conditions that nifedipine is used to treat. It also has a number of other medicinal uses, including for conditions including ryanoids syndrome and cephalagra. Market expansion drivers include an ageing population, rising healthcare costs, rising rates of chronic conditions like heart failure, arrhythmias, and hypertension, and rising consumer awareness of the importance of preventative treatment. Market expansion is hampered, however, by both strict government controls and unwanted medication effects include hypotension, stomach ulcers, and congestive heart failure. Opportunities for expansion are expected to arise as a result of ongoing research and development.
We were also tracking the indirect effects of covid-19 across sectors to see how they may affect this market. The impact of the pandemic on the Nifedipine market is examined in this report, both globally and regionally. Market size, market trends, and market expansion are provided for the Nifedipine market, which is broken down here by product type, application, and end-use industry. It also offers a thorough assessment of the factors involved in the growth of the market before and during the covid-19 pandemic. In addition, a pestel analysis of the company's main influencers and entrance barriers was conducted for this report.
Nifedipine works by preventing calcium from crossing the arterial wall and thereby lowering blood pressure. Nifedipine is used to treat hypertension, heart rhythm disorders, and angina. Ryanoids syndrome, cephalalgia, and other illnesses of a similar origin are also treated with this medication. Market growth is being fueled by a number of factors, including an ageing population, rising healthcare spending, an increase in chronic diseases such heart failure, arrhythmias, and hypertension, and an increase in healthcare awareness. However, market growth is hampered by government regulations and negative pharmacological effects include hypotension, stomach ulcers, and congestive heart failure. It is anticipated that the results of R&D efforts would pave the way for further expansion. Nitrendipine and nisoldipine are two examples of dihydropyridine calcium channel blockers used to treat hypertension. Demand for these drugs has increased as the incidence of premature labour has increased in recent years.
This report examines the nifedipine market thoroughly, detailing its history, present state, and projected future state in order to highlight promising investment areas. Both the forces driving and restraining the expansion of the industry have been thoroughly examined. To help stakeholders make the most of the present market prospects, the research offers a quantitative analysis of those potential. Understanding the market's many products requires a deep dive into its many subsets. The competitive outlook of the market has been predicted by profiling key competitors and closely analysing their strategies.
The overall number of people with hypertension is predicted to climb in the future decades as a result of the ageing population and the increasing incidence of obesity and diabetes across Asia. Asia is the largest and most populous continent, home to 60% of the world's current human population of 4.3 billion people and growing rapidly. As a result, hypertension affects a sizable percentage of the population, suggesting rising need for Nifedipine. Nifedipine, a dihydropyridine calcium channel blocker, used to be one of the most widely used hypertension medications, but its popularity has since waned due to safety and tolerability concerns, the introduction of new classes of antihypertensive medications, and an increasing body of data showing the mortality benefit of other classes.
Report Coverage
Global Nifedipine research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Nifedipine report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Nifedipine competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Nifedipine market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Boehringer Ingelheim GmbH, Novartis AG, Vectura Group plc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, F. Hoffmann La Roche AG, Merck and Co., Inc., Pfizer Inc., GlaxoSmithKline plc |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Nifedipine Market from 2021 to 2030.
- Market Forecast for Nifedipine Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Nifedipine competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Nifedipine
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Nifedipine market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Nifedipine market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Boehringer Ingelheim GmbH, Novartis AG, Vectura Group plc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, F. Hoffmann La Roche AG, Merck and Co., Inc., Pfizer Inc., GlaxoSmithKline plc
Primary Target Market
- Market Players of Nifedipine
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Nifedipine market based on the below-mentioned segments:
Global Nifedipine Market, By Product
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Global Nifedipine market, By Application
Primary Pulmonary Hypertension
Heart Failure
Raynauds Syndrome
Cephalagra
Bronchial Asthma
Premature Labor
Global Nifedipine market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive nifedipine market market research and competitor analysis for your business to help you develop more profound insights into the nifedipine market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the nifedipine market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.